1. Product Overview
1.1.
Market
Definition
1.2.
Scope
of the Market
1.2.1.
Markets
Covered
1.2.2.
Years
Considered for Study
1.2.3.
Key
Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1.
Overview
of the Market
3.2.
Overview
of Key Market Segmentations
3.3.
Overview
of Key Market Players
3.4.
Overview
of Key Regions/Countries
3.5.
Overview
of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Global
Hospital Acquired Infection Control Market Outlook
5.1. Market Size & Forecast
5.1.1.
By
Value
5.2. Market Share & Forecast
5.2.1.
By Product
(Sterilizers, Disinfectors, Endoscope Reprocessors, Others)
5.2.2.
By
Application (Disease Testing, Drug-Resistance Testing)
5.2.3.
By
Technology (Phenotypic Methods, Genotypic Methods)
5.2.4.
By
Disease (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site
Infections, Gastrointestinal Infections, UTI, Others)
5.2.5.
By
End User (Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing
Homes, Maternity Centers, Others)
5.2.6.
By
Region
5.2.7.
By
Company (2023)
5.3. Market Map
6.
North
America Hospital Acquired Infection Control Market Outlook
6.1. Market Size & Forecast
6.1.1.
By
Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2.
By
Application
6.2.3.
By
Technology
6.2.4.
By
Disease
6.2.5.
By
End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1.
United
States Hospital Acquired Infection Control Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By
Product
6.3.1.2.2.
By
Application
6.3.1.2.3.
By
Technology
6.3.1.2.4.
By
Disease
6.3.1.2.5.
By
End User
6.3.2.
Canada
Hospital Acquired Infection Control Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By
Product
6.3.2.2.2.
By
Application
6.3.2.2.3.
By
Technology
6.3.2.2.4.
By
Disease
6.3.2.2.5.
By
End User
6.3.3.
Mexico
Hospital Acquired Infection Control Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By
Product
6.3.3.2.2.
By
Application
6.3.3.2.3.
By
Technology
6.3.3.2.4.
By
Disease
6.3.3.2.5.
By
End User
7.
Europe
Hospital Acquired Infection Control Market Outlook
7.1. Market Size & Forecast
7.1.1.
By
Value
7.2. Market Share & Forecast
7.2.1.
By
Product
7.2.2.
By
Application
7.2.3.
By
Technology
7.2.4.
By
Disease
7.2.5.
By
End User
7.2.6.
By
Country
7.3. Europe: Country Analysis
7.3.1.
Germany
Hospital Acquired Infection Control Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By
Product
7.3.1.2.2.
By
Application
7.3.1.2.3.
By
Technology
7.3.1.2.4.
By
Disease
7.3.1.2.5.
By
End User
7.3.2.
United
Kingdom Hospital Acquired Infection Control Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By
Product
7.3.2.2.2.
By
Application
7.3.2.2.3.
By
Technology
7.3.2.2.4.
By
Disease
7.3.2.2.5.
By
End User
7.3.3.
Italy
Hospital Acquired Infection Control Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By
Product
7.3.3.2.2.
By
Application
7.3.3.2.3.
By
Technology
7.3.3.2.4.
By
Disease
7.3.3.2.5.
By
End User
7.3.4.
France
Hospital Acquired Infection Control Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By
Product
7.3.4.2.2.
By
Application
7.3.4.2.3.
By
Technology
7.3.4.2.4.
By
Disease
7.3.4.2.5.
By
End User
7.3.5.
Spain
Hospital Acquired Infection Control Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By
Product
7.3.5.2.2.
By
Application
7.3.5.2.3.
By
Technology
7.3.5.2.4.
By
Disease
7.3.5.2.5.
By
End User
8.
Asia-Pacific
Hospital Acquired Infection Control Market Outlook
8.1. Market Size & Forecast
8.1.1.
By
Value
8.2. Market Share & Forecast
8.2.1.
By
Product
8.2.2.
By
Application
8.2.3.
By
Technology
8.2.4.
By
Disease
8.2.5.
By
End User
8.2.6.
By
Country
8.3. Asia-Pacific: Country Analysis
8.3.1.
China
Hospital Acquired Infection Control Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By
Product
8.3.1.2.2.
By
Application
8.3.1.2.3.
By
Technology
8.3.1.2.4.
By
Disease
8.3.1.2.5.
By
End User
8.3.2.
India
Hospital Acquired Infection Control Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By
Product
8.3.2.2.2.
By
Application
8.3.2.2.3.
By
Technology
8.3.2.2.4.
By
Disease
8.3.2.2.5.
By
End User
8.3.3.
Japan
Hospital Acquired Infection Control Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By
Product
8.3.3.2.2.
By
Application
8.3.3.2.3.
By
Technology
8.3.3.2.4.
By
Disease
8.3.3.2.5.
By
End User
8.3.4.
South
Korea Hospital Acquired Infection Control Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By
Product
8.3.4.2.2.
By
Application
8.3.4.2.3.
By
Technology
8.3.4.2.4.
By
Disease
8.3.4.2.5.
By
End User
8.3.5.
Australia
Hospital Acquired Infection Control Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By
Product
8.3.5.2.2.
By
Application
8.3.5.2.3.
By
Technology
8.3.5.2.4.
By
Disease
8.3.5.2.5.
By
End User
9.
South
America Hospital Acquired Infection Control Market Outlook
9.1. Market Size & Forecast
9.1.1.
By
Value
9.2. Market Share & Forecast
9.2.1.
By
Product
9.2.2.
By
Application
9.2.3.
By
Technology
9.2.4.
By
Disease
9.2.5.
By
End User
9.2.6.
By
Country
9.3. South America: Country Analysis
9.3.1.
Brazil
Hospital Acquired Infection Control Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By
Product
9.3.1.2.2.
By
Application
9.3.1.2.3.
By
Technology
9.3.1.2.4.
By
Disease
9.3.1.2.5.
By
End User
9.3.2.
Argentina
Hospital Acquired Infection Control Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By
Product
9.3.2.2.2.
By
Application
9.3.2.2.3.
By
Technology
9.3.2.2.4.
By
Disease
9.3.2.2.5.
By
End User
9.3.3.
Colombia
Hospital Acquired Infection Control Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By
Product
9.3.3.2.2.
By
Application
9.3.3.2.3.
By
Technology
9.3.3.2.4.
By
Disease
9.3.3.2.5.
By
End User
10. Middle East and Africa Hospital Acquired
Infection Control Market Outlook
10.1.
Market
Size & Forecast
10.1.1. By Value
10.2.
Market
Share & Forecast
10.2.1. By Product
10.2.2. By Application
10.2.3. By Technology
10.2.4. By Disease
10.2.5. By End User
10.2.6. By Country
10.3.
MEA:
Country Analysis
10.3.1. South Africa Hospital Acquired Infection
Control Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By
Product
10.3.1.2.2.
By
Application
10.3.1.2.3.
By
Technology
10.3.1.2.4.
By
Disease
10.3.1.2.5.
By
End User
10.3.2. Saudi Arabia Hospital Acquired Infection
Control Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By
Product
10.3.2.2.2.
By
Application
10.3.2.2.3.
By
Technology
10.3.2.2.4.
By
Disease
10.3.2.2.5.
By
End User
10.3.3. UAE Hospital Acquired Infection Control
Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By
Product
10.3.3.2.2.
By
Application
10.3.3.2.3.
By
Technology
10.3.3.2.4.
By
Disease
10.3.3.2.5.
By
End User
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Merger
& Acquisition (If Any)
12.2.
Product
Launches (If Any)
12.3.
Recent
Developments
13. Porter’s Five Forces Analysis
13.1.
Competition
in the Industry
13.2.
Potential
of New Entrants
13.3.
Power
of Suppliers
13.4.
Power
of Customers
13.5.
Threat
of Substitute Products
14. Competitive Landscape
14.1.
Becton, Dickinson and Company
14.1.1. Business
Overview
14.1.2. Company
Snapshot
14.1.3. Products
& Services
14.1.4. Financials
(As Reported)
14.1.5. Recent
Developments
14.1.6. Key
Personnel Details
14.1.7. SWOT
Analysis
14.2.
STERIS Plc
14.3.
Advanced Sterilization Products Services Inc.
14.4.
Getinge AB
14.5.
Kimberly-Clark Corporation
14.6.
Cantel Medical Corporation
14.7.
BioMérieux SA
14.8.
Belimed AG
14.9.
3M Company
14.10.
Sterigenics International LLC
15. Strategic Recommendations
16. About Us & Disclaimer